IL-6-activated STAT3 bound to the promoter of the B7-H4 gene and enhanced B7-H4 expression on TAMs, resulting in an immunosuppressive phenotype of TAMs, which contributed to GBM progression (84). Here, VTCN1 is linked to glioblastoma.